Prognostic factors in resected pathological N1-stage II nonsmall cell lung cancer

Liu Chao-Yu, Hung Jung-Jyh, Wang Bing-Yen, Hsu Wen-Hu, Wu Yu-Chung

Source: Eur Respir J 2013; 41: 649-655
Journal Issue: March
Disease area: Thoracic oncology

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Liu Chao-Yu, Hung Jung-Jyh, Wang Bing-Yen, Hsu Wen-Hu, Wu Yu-Chung. Prognostic factors in resected pathological N1-stage II nonsmall cell lung cancer. Eur Respir J 2013; 41: 649-655

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic factors in patients with resected pathologic stage I and II nonsmall cell lung cancer (NSCLC)
Source: Eur Respir J 2002; 20: Suppl. 38, 269s
Year: 2002

Prognostic factors in pathological stage IB nonsmall cell lung cancer greater than 3 cm
Source: Eur Respir J 2010; 36: 1355-1361
Year: 2010



Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012


Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment
Source: Eur Respir J 2009; 33: 1383-1388
Year: 2009



Analysis of prognostic factors in patients with stage IIIB, IV non-small cell lung cancer
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010


Immunohistochemical study of intratumoral micro vessels in resected non-small cell lung carcinomas, N-status, pTNM-stage and survival period of the patients
Source: Annual Congress 2007 - Biology of thoracic malignancies
Year: 2007


Independent prognostic und predictive value of blood vessel invasion (BVI) in curatively (R0) resected stage II and IIIA non-small cell lung (NSCLC) cancer patients
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012

The prognostic impact of stage and performance status on surgically resected non-small cell lung cancer
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012

Is the highest mediastinal lymph node a prognostic factor in stage IIIA N2 NSCLC?
Source: ISSN=ISSN 1810-6838, ISBN=, page=355
Year: 2006

Prognostic value of Her2/neu in stage IIIA non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 770s
Year: 2006

Intratumoral microvessels, pTNM stage and survival in resected NSCLC
Source: Eur Respir J 2005; 26: Suppl. 49, 325s
Year: 2005

Imaging for staging stage III nonsmall cell lung cancer
Source: ISSN=ISSN 1810-6838, ISBN=, page=47
Year: 2007

Objective measurement of tumor central location can predict nodal involvement in patients with cT1N0M0 non-small cell lung cancer
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020


Age and stage at presentation in lung cancer
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005


Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease?
Source: Eur Respir J, 53 (3) 1801508; 10.1183/13993003.01508-2018
Year: 2019



Staging of lung cancer
Source: Eur Respir Mon; 2009: 44: 150–168
Year: 2009

The relation between clinical tumor stage and metastasis according to sixth TNM staging and new revised TNM staging in non-small lung cancer patients
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010


Assessment of DNA ploidy and proliferating activity changes in neoplasmatic cells according to TNM classification and clinical stages in non-small cell lung cancer (NSCLC) patients during chemotherapy
Source: Eur Respir J 2003; 22: Suppl. 45, 225s
Year: 2003

Accuracy of re-mediastinoscopy and fusion PET-CT in the assessment of lymph node (LN) downstaging after induction chemotherapy for N2 non-small cell lung cancer (NSCLC)
Source: Eur Respir J 2006; 28: Suppl. 50, 602s
Year: 2006